Page 6 - Optimizerx Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Optimizerx co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Optimizerx Co Today - Breaking & Trending Today

Head to Head Survey: OptimizeRx (NASDAQ:OPRX) and Emerald (NYSE:EEX)

OptimizeRx (NASDAQ:OPRX – Get Rating) and Emerald (NYSE:EEX – Get Rating) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, analyst recommendations, institutional ownership, earnings and dividends. Institutional and Insider Ownership 80.4% of OptimizeRx shares are […] ....

New York , United States , Davida Harrell , Optimizerx Corp , Emerald Holding Inc , Get Rating , Given Optimizerx , Optimizerx Daily , Nasdaq Oprx , Computer And Technology , Stock Comparison , Stock Analysis ,

Federated Hermes Inc. Has $1.68 Million Stake in OptimizeRx Co. (NASDAQ:OPRX)

Federated Hermes Inc. raised its holdings in OptimizeRx Co. (NASDAQ:OPRX – Get Rating) by 785.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 113,520 shares of the company’s stock after buying an additional 100,698 shares during the period. Federated Hermes Inc.’s holdings in OptimizeRx […] ....

Stifel Nicolaus , Northern Trust Corp , Blackrock Inc , Renaissance Technologies , Optimizerx Co , Exchange Commission , Optimizerx Corp , Victory Capital Management Inc , Hermes Inc , Federated Hermes , Get Rating , Trust Corp , Victory Capital Management , Capital Management , Lake Street Capital , Roth Capital , Visit Holdingschannel , Optimizerx Daily , Nasdaq Oprx , Computer And Technology , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Zacks: Brokerages Anticipate OptimizeRx Co. (NASDAQ:OPRX) Will Announce Quarterly Sales of $17.60 Million

Equities research analysts forecast that OptimizeRx Co. (NASDAQ:OPRX – Get Rating) will announce sales of $17.60 million for the current quarter, Zacks Investment Research reports. Three analysts have provided estimates for OptimizeRx’s earnings, with the highest sales estimate coming in at $17.94 million and the lowest estimate coming in at $17.15 million. OptimizeRx posted sales […] ....

United States , Hong Kong , Zurcher Kantonalbank Zurich Cantonalbank , Harel Insurance Investments Financial Services Ltd , Zacks Investment Research , Optimizerx Corporation , Mutual Of America Capital Management , Optimizerx Co , Royal Bank , Hong Kong Ltd , Optimizerx Company Profile Get Rating , Get Rating , Investment Research , Street Capital , Roth Capital , Insurance Investments , Financial Services , Kong Ltd , Kantonalbank Zurich Cantonalbank , America Capital Management , Teacher Retirement System , Nasdaq Oprx , Computer And Technology ,

OptimizeRx Co. (NASDAQ:OPRX) Expected to Post Quarterly Sales of $17.60 Million

Equities analysts predict that OptimizeRx Co. (NASDAQ:OPRX – Get Rating) will announce sales of $17.60 million for the current fiscal quarter, according to Zacks. Three analysts have made estimates for OptimizeRx’s earnings, with estimates ranging from $17.15 million to $17.94 million. OptimizeRx reported sales of $13.63 million in the same quarter last year, which indicates […] ....

United States , Williamj Febbo , American Century Companies Inc , Securities Exchange Commission , Mount Capital Ltd , Zacks Investment Research , Optimizerx Corporation , Optimizerx Co , York Mellon Corp , Tennessee Treasury Department , Raymond James Associates , Royal Bank , Optimizerx Company Profile Get Rating , Get Rating , Investment Research , Lake Street Capital , Exchange Commission , Century Companies , New York Mellon Corp , Capital Ltd , Nasdaq Oprx , Computer And Technology ,

OptimizeRx Co. (NASDAQ:OPRX) Expected to Post Quarterly Sales of $14.49 Million

Wall Street brokerages forecast that OptimizeRx Co. (NASDAQ:OPRX – Get Rating) will post $14.49 million in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for OptimizeRx’s earnings, with estimates ranging from $13.68 million to $15.19 million. OptimizeRx reported sales of $11.23 million during the same quarter last year, […] ....

New York , United States , Williamj Febbo , Morgan Stanley , York State Common Retirement Fund , Zacks Investment Research , Optimizerx Corporation , Optimizerx Co , Sg Americas Securities , Victory Capital Management Inc , Optimizerx Company Profile Get Rating , Wall Street , Get Rating , Street Capital , Capital Management , New York State Common Retirement Fund , Nasdaq Oprx , Computer And Technology ,